0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2019-2025
Published Date: October 2019
|
Report Code: QYRE-Auto-29M171
Home | Category |Health |Health Conditions |Heart & Hypertension
Global Acute Ischemic Stroke Drugs Market Size Status and Forecast 2019 2025

Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2019-2025

Code: QYRE-Auto-29M171
Report
October 2019
98 Pages
QYResearch
Region: Global, Europe, North America, Japan, China,
Description
Table of Content
Tables & Figures
Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important central nervous system vascular events.
In 2018, the global Acute Ischemic Stroke Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.
The key players covered in this study
    Sanofi
    Biogen
    Bayer
    Pfizer
    Roche
    Boehringer Ingelheim
    Daiichi Sankyo
    Bristol-Myers Squibb
    Johnson&Johnson
    AstraZeneca
    ZZ Biotech
    NoNO Inc
    Athersys
    SanBio
Market segment by Type, the product can be split into
    Tablet
    Capsule
    Other
Market segment by Application, split into
    Hospitals
    Diagnostic Centers
    Others
Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
The study objectives of this report are:
    To analyze global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Acute Ischemic Stroke Drugs are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Tablet
1.4.3 Capsule
1.4.4 Other
1.5 Market by Application
1.5.1 Global Acute Ischemic Stroke Drugs Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Acute Ischemic Stroke Drugs Market Size
2.2 Acute Ischemic Stroke Drugs Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Drugs Market Size by Regions (2019-2025)
2.2.2 Acute Ischemic Stroke Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Acute Ischemic Stroke Drugs Market Size by by Players
3.1.1 Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019)
3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Acute Ischemic Stroke Drugs Key Players Head office and Area Served
3.3 Key Players Acute Ischemic Stroke Drugs Product/Solution/Service
3.4 Date of Enter into Acute Ischemic Stroke Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019)
4.2 Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Acute Ischemic Stroke Drugs Market Size (2014-2019)
5.2 Acute Ischemic Stroke Drugs Key Players in North America
5.3 North America Acute Ischemic Stroke Drugs Market Size by Type
5.4 North America Acute Ischemic Stroke Drugs Market Size by Application
6 Europe
6.1 Europe Acute Ischemic Stroke Drugs Market Size (2014-2019)
6.2 Acute Ischemic Stroke Drugs Key Players in Europe
6.3 Europe Acute Ischemic Stroke Drugs Market Size by Type
6.4 Europe Acute Ischemic Stroke Drugs Market Size by Application
7 China
7.1 China Acute Ischemic Stroke Drugs Market Size (2014-2019)
7.2 Acute Ischemic Stroke Drugs Key Players in China
7.3 China Acute Ischemic Stroke Drugs Market Size by Type
7.4 China Acute Ischemic Stroke Drugs Market Size by Application
8 Japan
8.1 Japan Acute Ischemic Stroke Drugs Market Size (2014-2019)
8.2 Acute Ischemic Stroke Drugs Key Players in Japan
8.3 Japan Acute Ischemic Stroke Drugs Market Size by Type
8.4 Japan Acute Ischemic Stroke Drugs Market Size by Application
9 International Players Profiles
9.1 Sanofi
9.1.1 Sanofi Company Details
9.1.2 Company Description and Business Overview
9.1.3 Acute Ischemic Stroke Drugs Introduction
9.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2014-2019))
9.1.5 Sanofi Recent Development
9.2 Biogen
9.2.1 Biogen Company Details
9.2.2 Company Description and Business Overview
9.2.3 Acute Ischemic Stroke Drugs Introduction
9.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.2.5 Biogen Recent Development
9.3 Bayer
9.3.1 Bayer Company Details
9.3.2 Company Description and Business Overview
9.3.3 Acute Ischemic Stroke Drugs Introduction
9.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.3.5 Bayer Recent Development
9.4 Pfizer
9.4.1 Pfizer Company Details
9.4.2 Company Description and Business Overview
9.4.3 Acute Ischemic Stroke Drugs Introduction
9.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.4.5 Pfizer Recent Development
9.5 Roche
9.5.1 Roche Company Details
9.5.2 Company Description and Business Overview
9.5.3 Acute Ischemic Stroke Drugs Introduction
9.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.5.5 Roche Recent Development
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Company Details
9.6.2 Company Description and Business Overview
9.6.3 Acute Ischemic Stroke Drugs Introduction
9.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.6.5 Boehringer Ingelheim Recent Development
9.7 Daiichi Sankyo
9.7.1 Daiichi Sankyo Company Details
9.7.2 Company Description and Business Overview
9.7.3 Acute Ischemic Stroke Drugs Introduction
9.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.7.5 Daiichi Sankyo Recent Development
9.8 Bristol-Myers Squibb
9.8.1 Bristol-Myers Squibb Company Details
9.8.2 Company Description and Business Overview
9.8.3 Acute Ischemic Stroke Drugs Introduction
9.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.8.5 Bristol-Myers Squibb Recent Development
9.9 Johnson&Johnson
9.9.1 Johnson&Johnson Company Details
9.9.2 Company Description and Business Overview
9.9.3 Acute Ischemic Stroke Drugs Introduction
9.9.4 Johnson&Johnson Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.9.5 Johnson&Johnson Recent Development
9.10 AstraZeneca
9.10.1 AstraZeneca Company Details
9.10.2 Company Description and Business Overview
9.10.3 Acute Ischemic Stroke Drugs Introduction
9.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.10.5 AstraZeneca Recent Development
9.11 ZZ Biotech
9.12 NoNO Inc
9.13 Athersys
9.14 SanBio
10 Market Forecast 2019-2025
10.1 Market Size Forecast by Product (2019-2025)
10.2 Market Size Forecast by Application (2019-2025)
10.3 Market Size Forecast by Regions
10.4 North America
10.5 Europe
10.6 China
10.7 Japan
11 Analyst's Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Detail
List of Tables and Figures
    Table Acute Ischemic Stroke Drugs Key Market Segments
    Table Key Players Acute Ischemic Stroke Drugs Covered
    Table Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
    Figuer Tablet Figures
    Table Key Players of Tablet
    Figuer Capsule Figures
    Table Key Players of Capsule
    Figuer Other Figures
    Table Key Players of Other
    Table Global Acute Ischemic Stroke Drugs Market Size Growth by Application 2019-2025 (Million US$)
    Figure Global Acute Ischemic Stroke Drugs Market Share by Application in 2018 & 2025
    Figure Hospitals Case Studies
    Figure Diagnostic Centers Case Studies
    Figure Others Case Studies
    Figure Acute Ischemic Stroke Drugs Report Years Considered
    Figure Global Acute Ischemic Stroke Drugs Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size by Regions 2019-2025 (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size by Regions 2019-2025 (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019
    Figure Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019
    Figure Global Acute Ischemic Stroke Drugs Market Share by Regions in 2018
    Table Market Top Trends
    Table Key Drivers: Impact Analysis (2019-2025)
    Table Key Challenges
    Figure PORTER'S FIVE FORCES ANALYSIS
    Table Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019) (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Share by by Players (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Market Share by by Players in 2018
    Table Global Acute Ischemic Stroke Drugs by Players Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Acute Ischemic Stroke Drugs Product/Solution/Service
    Table Date of Enter into Acute Ischemic Stroke Drugs Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size Share by Type (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Type (2014-2019)
    Table Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size Share by Application (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Application (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Revenue Market Share by Application in 2018
    Figure North America Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table North America Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table North America Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table North America Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table North America Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table North America Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table North America Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Figure Europe Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table Europe Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table Europe Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table Europe Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table Europe Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table Europe Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table Europe Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Figure China Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table China Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table China Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table China Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table China Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table China Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table China Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Figure Japan Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table Japan Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table Japan Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table Japan Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table Japan Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table Japan Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table Japan Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Table Sanofi Company Details
    Table Sanofi Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Sanofi Recent Development
    Table Biogen Company Details
    Table Biogen Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Biogen Recent Development
    Table Bayer Company Details
    Table Bayer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Bayer Recent Development
    Table Pfizer Company Details
    Table Pfizer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Pfizer Recent Development
    Table Roche Company Details
    Table Roche Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Roche Recent Development
    Table Boehringer Ingelheim Company Details
    Table Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Boehringer Ingelheim Recent Development
    Table Daiichi Sankyo Company Details
    Table Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Daiichi Sankyo Recent Development
    Table Bristol-Myers Squibb Company Details
    Table Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Bristol-Myers Squibb Recent Development
    Table Johnson&Johnson Company Details
    Table Johnson&Johnson Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Johnson&Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Johnson&Johnson Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table AstraZeneca Recent Development
    Table ZZ Biotech Company Details
    Table NoNO Inc Company Details
    Table Athersys Company Details
    Table SanBio Company Details
    Table Global Acute Ischemic Stroke Drugs Market Size by Regions (Million US$) 2019-2025
    Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions (2019-2025)
    Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions in 2025
    Figure North America Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure China Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Table Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025) (Million US$)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Product in 2025
    Table Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025) (Million US$)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important central nervous system vascular events.
In 2018, the global Acute Ischemic Stroke Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.
The key players covered in this study
    Sanofi
    Biogen
    Bayer
    Pfizer
    Roche
    Boehringer Ingelheim
    Daiichi Sankyo
    Bristol-Myers Squibb
    Johnson&Johnson
    AstraZeneca
    ZZ Biotech
    NoNO Inc
    Athersys
    SanBio
Market segment by Type, the product can be split into
    Tablet
    Capsule
    Other
Market segment by Application, split into
    Hospitals
    Diagnostic Centers
    Others
Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
The study objectives of this report are:
    To analyze global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Acute Ischemic Stroke Drugs are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered
Read More
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Tablet
1.4.3 Capsule
1.4.4 Other
1.5 Market by Application
1.5.1 Global Acute Ischemic Stroke Drugs Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Acute Ischemic Stroke Drugs Market Size
2.2 Acute Ischemic Stroke Drugs Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Drugs Market Size by Regions (2019-2025)
2.2.2 Acute Ischemic Stroke Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Acute Ischemic Stroke Drugs Market Size by by Players
3.1.1 Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019)
3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Acute Ischemic Stroke Drugs Key Players Head office and Area Served
3.3 Key Players Acute Ischemic Stroke Drugs Product/Solution/Service
3.4 Date of Enter into Acute Ischemic Stroke Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019)
4.2 Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Acute Ischemic Stroke Drugs Market Size (2014-2019)
5.2 Acute Ischemic Stroke Drugs Key Players in North America
5.3 North America Acute Ischemic Stroke Drugs Market Size by Type
5.4 North America Acute Ischemic Stroke Drugs Market Size by Application
6 Europe
6.1 Europe Acute Ischemic Stroke Drugs Market Size (2014-2019)
6.2 Acute Ischemic Stroke Drugs Key Players in Europe
6.3 Europe Acute Ischemic Stroke Drugs Market Size by Type
6.4 Europe Acute Ischemic Stroke Drugs Market Size by Application
7 China
7.1 China Acute Ischemic Stroke Drugs Market Size (2014-2019)
7.2 Acute Ischemic Stroke Drugs Key Players in China
7.3 China Acute Ischemic Stroke Drugs Market Size by Type
7.4 China Acute Ischemic Stroke Drugs Market Size by Application
8 Japan
8.1 Japan Acute Ischemic Stroke Drugs Market Size (2014-2019)
8.2 Acute Ischemic Stroke Drugs Key Players in Japan
8.3 Japan Acute Ischemic Stroke Drugs Market Size by Type
8.4 Japan Acute Ischemic Stroke Drugs Market Size by Application
9 International Players Profiles
9.1 Sanofi
9.1.1 Sanofi Company Details
9.1.2 Company Description and Business Overview
9.1.3 Acute Ischemic Stroke Drugs Introduction
9.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2014-2019))
9.1.5 Sanofi Recent Development
9.2 Biogen
9.2.1 Biogen Company Details
9.2.2 Company Description and Business Overview
9.2.3 Acute Ischemic Stroke Drugs Introduction
9.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.2.5 Biogen Recent Development
9.3 Bayer
9.3.1 Bayer Company Details
9.3.2 Company Description and Business Overview
9.3.3 Acute Ischemic Stroke Drugs Introduction
9.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.3.5 Bayer Recent Development
9.4 Pfizer
9.4.1 Pfizer Company Details
9.4.2 Company Description and Business Overview
9.4.3 Acute Ischemic Stroke Drugs Introduction
9.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.4.5 Pfizer Recent Development
9.5 Roche
9.5.1 Roche Company Details
9.5.2 Company Description and Business Overview
9.5.3 Acute Ischemic Stroke Drugs Introduction
9.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.5.5 Roche Recent Development
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Company Details
9.6.2 Company Description and Business Overview
9.6.3 Acute Ischemic Stroke Drugs Introduction
9.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.6.5 Boehringer Ingelheim Recent Development
9.7 Daiichi Sankyo
9.7.1 Daiichi Sankyo Company Details
9.7.2 Company Description and Business Overview
9.7.3 Acute Ischemic Stroke Drugs Introduction
9.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.7.5 Daiichi Sankyo Recent Development
9.8 Bristol-Myers Squibb
9.8.1 Bristol-Myers Squibb Company Details
9.8.2 Company Description and Business Overview
9.8.3 Acute Ischemic Stroke Drugs Introduction
9.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.8.5 Bristol-Myers Squibb Recent Development
9.9 Johnson&Johnson
9.9.1 Johnson&Johnson Company Details
9.9.2 Company Description and Business Overview
9.9.3 Acute Ischemic Stroke Drugs Introduction
9.9.4 Johnson&Johnson Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.9.5 Johnson&Johnson Recent Development
9.10 AstraZeneca
9.10.1 AstraZeneca Company Details
9.10.2 Company Description and Business Overview
9.10.3 Acute Ischemic Stroke Drugs Introduction
9.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2014-2019)
9.10.5 AstraZeneca Recent Development
9.11 ZZ Biotech
9.12 NoNO Inc
9.13 Athersys
9.14 SanBio
10 Market Forecast 2019-2025
10.1 Market Size Forecast by Product (2019-2025)
10.2 Market Size Forecast by Application (2019-2025)
10.3 Market Size Forecast by Regions
10.4 North America
10.5 Europe
10.6 China
10.7 Japan
11 Analyst's Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Detail
Read More
List of Tables and Figures
    Table Acute Ischemic Stroke Drugs Key Market Segments
    Table Key Players Acute Ischemic Stroke Drugs Covered
    Table Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
    Figuer Tablet Figures
    Table Key Players of Tablet
    Figuer Capsule Figures
    Table Key Players of Capsule
    Figuer Other Figures
    Table Key Players of Other
    Table Global Acute Ischemic Stroke Drugs Market Size Growth by Application 2019-2025 (Million US$)
    Figure Global Acute Ischemic Stroke Drugs Market Share by Application in 2018 & 2025
    Figure Hospitals Case Studies
    Figure Diagnostic Centers Case Studies
    Figure Others Case Studies
    Figure Acute Ischemic Stroke Drugs Report Years Considered
    Figure Global Acute Ischemic Stroke Drugs Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size by Regions 2019-2025 (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size by Regions 2019-2025 (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019
    Figure Global Acute Ischemic Stroke Drugs Market Share by Regions 2014-2019
    Figure Global Acute Ischemic Stroke Drugs Market Share by Regions in 2018
    Table Market Top Trends
    Table Key Drivers: Impact Analysis (2019-2025)
    Table Key Challenges
    Figure PORTER'S FIVE FORCES ANALYSIS
    Table Global Acute Ischemic Stroke Drugs Revenue by by Players (2014-2019) (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Share by by Players (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Market Share by by Players in 2018
    Table Global Acute Ischemic Stroke Drugs by Players Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Acute Ischemic Stroke Drugs Product/Solution/Service
    Table Date of Enter into Acute Ischemic Stroke Drugs Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Acute Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size Share by Type (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Type (2014-2019)
    Table Global Acute Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
    Table Global Acute Ischemic Stroke Drugs Market Size Share by Application (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Market Size Market Share by Application (2014-2019)
    Figure Global Acute Ischemic Stroke Drugs Revenue Market Share by Application in 2018
    Figure North America Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table North America Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table North America Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table North America Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table North America Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table North America Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table North America Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Figure Europe Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table Europe Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table Europe Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table Europe Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table Europe Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table Europe Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table Europe Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Figure China Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table China Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table China Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table China Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table China Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table China Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table China Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Figure Japan Acute Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
    Table Japan Key Players Acute Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
    Table Japan Key Players Acute Ischemic Stroke Drugs Market Share (2018-2019)
    Table Japan Acute Ischemic Stroke Drugs Market Size by Type 2014-2019 (Million US$)
    Table Japan Acute Ischemic Stroke Drugs Market Share by Type 2014-2019
    Table Japan Acute Ischemic Stroke Drugs Market Size by Application 2014-2019 (Million US$)
    Table Japan Acute Ischemic Stroke Drugs Market Share by Application 2014-2019
    Table Sanofi Company Details
    Table Sanofi Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Sanofi Recent Development
    Table Biogen Company Details
    Table Biogen Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Biogen Recent Development
    Table Bayer Company Details
    Table Bayer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Bayer Recent Development
    Table Pfizer Company Details
    Table Pfizer Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Pfizer Recent Development
    Table Roche Company Details
    Table Roche Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Roche Recent Development
    Table Boehringer Ingelheim Company Details
    Table Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Boehringer Ingelheim Recent Development
    Table Daiichi Sankyo Company Details
    Table Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Daiichi Sankyo Recent Development
    Table Bristol-Myers Squibb Company Details
    Table Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Bristol-Myers Squibb Recent Development
    Table Johnson&Johnson Company Details
    Table Johnson&Johnson Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure Johnson&Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table Johnson&Johnson Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business 2014-2019 (Million US$)
    Figure AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2014-2019)
    Table AstraZeneca Recent Development
    Table ZZ Biotech Company Details
    Table NoNO Inc Company Details
    Table Athersys Company Details
    Table SanBio Company Details
    Table Global Acute Ischemic Stroke Drugs Market Size by Regions (Million US$) 2019-2025
    Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions (2019-2025)
    Figure Global Acute Ischemic Stroke Drugs Market Size Share by Regions in 2025
    Figure North America Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure China Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Acute Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
    Table Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025) (Million US$)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Product (2019-2025)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Product in 2025
    Table Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025) (Million US$)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Application (2019-2025)
    Figure Global Acute Ischemic Stroke Drugs Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Heart Catheterization Market Size Status and Forecast 2020 2026
Global Heart Catheterization Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-1K3431
Tue Aug 04 00:00:00 UTC 2020

Add to Cart

Global Medical Heart Stents Market Research Report 2020
Global Medical Heart Stents Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-15K3146
Mon Jul 20 00:00:00 UTC 2020

Add to Cart

Global Cardiovascular Disease Diagnostic Equipment Market Insights and Forecast to 2026
Global Cardiovascular Disease Diagnostic Equipment Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-29R2939
Fri Jul 17 00:00:00 UTC 2020

Add to Cart

Global Cholesterol Testing Kits Market Insights and Forecast to 2026
Global Cholesterol Testing Kits Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-38F2898
Fri Jul 17 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0